Peskind ER - Search Results

1

Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease.

Watson GS, Bernhardt T, Reger MA, Cholerton BA, Baker LD, Peskind ER, Asthana S, Plymate SR, Frölich L, Craft S. Watson GS, et al. Among authors: peskind er. Neurobiol Aging. 2006 Jan;27(1):38-41. doi: 10.1016/j.neurobiolaging.2004.11.011. Neurobiol Aging. 2006. PMID: 16298239 Clinical Trial.

2

Neuroendocrine responses to physostigmine in Alzheimer's disease.

Raskind MA, Peskind ER, Veith RC, Risse SC, Lampe TH, Borson S, Gumbrecht G, Dorsa DM. Raskind MA, et al. Among authors: peskind er. Arch Gen Psychiatry. 1989 Jun;46(6):535-40. doi: 10.1001/archpsyc.1989.01810060057009. Arch Gen Psychiatry. 1989. PMID: 2525015

3

Yohimbine increases cerebrospinal fluid and plasma norepinephrine but not arginine vasopressin in humans.

Peskind ER, Veith RC, Dorsa DM, Gumbrecht G, Raskind MA. Peskind ER, et al. Neuroendocrinology. 1989 Sep;50(3):286-91. doi: 10.1159/000125235. Neuroendocrinology. 1989. PMID: 2552342 Clinical Trial.

4

Increased plasma and cerebrospinal fluid norepinephrine in older men: differential suppression by clonidine.

Raskind MA, Peskind ER, Veith RC, Beard JC, Gumbrecht G, Halter JB. Raskind MA, et al. Among authors: peskind er. J Clin Endocrinol Metab. 1988 Feb;66(2):438-43. doi: 10.1210/jcem-66-2-438. J Clin Endocrinol Metab. 1988. PMID: 3339115

5

Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.

Peskind ER, Wingerson D, Murray S, Pascualy M, Dobie DJ, Le Corre P, Le Verge R, Veith RC, Raskind MA. Peskind ER, et al. Arch Gen Psychiatry. 1995 Sep;52(9):774-82. doi: 10.1001/archpsyc.1995.03950210068012. Arch Gen Psychiatry. 1995. PMID: 7654129 Clinical Trial.

6

Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma.

Peskind ER, Wingerson D, Pascualy M, Thal L, Veith RC, Dorsa DM, Bodenheimer S, Raskind MA. Peskind ER, et al. Biol Psychiatry. 1995 Oct 15;38(8):532-8. doi: 10.1016/0006-3223(94)00377-F. Biol Psychiatry. 1995. PMID: 8562665

7

Plasma arginine vasopressin response to hypertonic saline infusion in Alzheimer disease.

Peskind ER, Pascualy M, Edland SD, Wingerson D, Dobie DJ, Raskind MA. Peskind ER, et al. Alzheimer Dis Assoc Disord. 1995 Winter;9(4):238-42. Alzheimer Dis Assoc Disord. 1995. PMID: 8749614

8

Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration.

Elrod R, Peskind ER, DiGiacomo L, Brodkin KI, Veith RC, Raskind MA. Elrod R, et al. Among authors: peskind er. Am J Psychiatry. 1997 Jan;154(1):25-30. doi: 10.1176/ajp.154.1.25. Am J Psychiatry. 1997. PMID: 8988954

9

Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls.

Peskind ER, Leverenz J, Farlow MR, Ito RK, Provow SA, Siegel RS, Cleveland M, Morgan CH, Pandian MR, Corbin S, Nochlin D, Schellenberg GD, Raskind MA, Wagner SL. Peskind ER, et al. Alzheimer Dis Assoc Disord. 1997 Dec;11(4):201-6. Alzheimer Dis Assoc Disord. 1997. PMID: 9437437

10

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D Jr. Craft S, et al. Neurology. 1998 Jan;50(1):164-8. doi: 10.1212/wnl.50.1.164. Neurology. 1998. PMID: 9443474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters